en · de · es · fr · pt
sermorelin-notes.peptides6908.com › News › Identity And Chemical Background — Hands-On Walkthrough

Identity And Chemical Background — Hands-On Walkthrough

By Editorial Desk · published 2025-12-27 · last reviewed 2026-01-13 · News

The short version of eumelanin fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2026-01-13 and is reviewed periodically as new material appears.

Identity and Chemical Background

Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.

Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.

The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.

Melanotan-2 Identity and Receptor Pharmacology

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Free base; salt forms differ
Molecular weightApproximately 1024 g/molCalculated for the free base
AppearanceWhite to off-white powderTypically supplied as a lyophilised solid
SolubilitySoluble in water and polar solventsPoorly soluble in non-polar solvents
Typical storage-20 degrees Celsius, dry, protected from lightRefers to the solid form

Melanotan-2 Structure and Receptor Pharmacology

No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.

Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.

Related pages on this site

Notes from published material

== Case Study: Ocean Euxinia == Because green-pigmented green sulfur bacteria require higher light intensities than their brown-pigmented counterparts, the presence of chlorobactane in the rock record has been used as key evidence in interpretations for a very shallow euxinic layer in the ocean. The euxinic zone may have changed depth in the ocean at various points in Earth's history, such as with the advent of an oxygenated atmosphere around 2.45 billion years ago and the shallowing of the oxic zone within the last six kyr.

. This is also equivalent to the assumption that the length of time spent by an individual in the infectious state is a random variable with an exponential distribution. The "classical" SIR model may be modified by using more complex and realistic distributions for the I-R transition rate (e.g. the Erlang distribution). For the special case in which there is no removal from the infectious compartment (

The Kenny Report on Sky News Australia Sky News on Sky News Australia Today on the Nine Network 7.30 on ABC TV Sunrise on Seven Network The Project on Network 10 A Current Affair on Nine Network Q+A on ABC TV ABC News on ABC News In 2021 he starred in television adverts on behalf of the Australian government about COVID-19 vaccinations. In 2023 Coatsworth filled in as presenter of Today while regular host Karl Stefanovic took Christmas leave. His appointment left "plenty of noses out of joint" due to his perceived inexperience.

=== Enzymatic labeling === In enzymatic labeling, a DNA construct is first formed, using a gene and the DNA of a fluorescent protein. After transcription, a hybrid RNA + fluorescent is formed. The object of interest is attached to an enzyme that can recognize this hybrid DNA. Usually fluorescein is used as the fluorophore.

Sources: en.wikipedia.org

Background from the literature

== Clinical significance == An inability to break down the proteoglycans is characteristic of a group of genetic disorders, called mucopolysaccharidoses. The inactivity of specific lysosomal enzymes that normally degrade glycosaminoglycans leads to the accumulation of proteoglycans within cells. This leads to a variety of disease symptoms, depending upon the type of proteoglycan that is not degraded. Mutations in the gene encoding the galactosyltransferase B4GALT7 result in a reduced substitution of the proteoglycans decorin and biglycan with glycosaminoglycan chains, and cause a spondylodysplastic form of Ehlers–Danlos syndrome.

genetic information stored in the sequence of DNA molecules a "messenger" RNA molecule to carry the instructions for making one protein to the cytoplasm adaptor molecules ("they might contain nucleotides") to match short sequences of nucleotides in the RNA messenger molecules to specific amino acids ribonucleic-protein complexes that catalyse the assembly of amino acids into proteins according to the messenger RNA The adaptor molecules were eventually shown to be tRNAs and the catalytic "ribonucleic-protein complexes" became known as ribosomes. An important step was the realisation by Crick and Brenner on 15 April 1960 during a conversation with François Jacob that messenger RNA was not the same thing as ribosomal RNA. Later that summer, Brenner, Jacob, and Matthew Meselson conducted an experiment which was the first to prove the existence of messenger RNA. None of this, however, answered the fundamental theoretical question of the exact nature of the genetic code. In his 1958 article, Crick speculated, as had others, that a triplet of nucleotides could code for an amino acid. Such a code might be "degenerate", with 4×4×4=64 possible triplets of the four nucleotide subunits while there were only 20 amino acids. Some amino acids might have multiple triplet codes. Crick also explored other codes in which, for various reasons, only some of the triplets were used, "magically" producing just the 20 needed combinations. Experimental results were needed; theory alone could not decide the nature of the code.

The gameplay involves capturing or defending Hybrid NPCs across four maps, incorporating mechanics inspired by Counter-Strike and Vampire Slayer. Vampire Slayer – is a teamplay mod where two sides: vampires and slayers, battle it out in a variety of atmospheric settings. Planet Half-Life called the original release "A great mod". They also reviewed Chapter IV and wrote: "The new maps fit perfectly with the atmosphere built up from the previous releases." PC Zone gave version 1.1 a rating of three out of five, Chapter III a rating of 69%, and Chapter V a rating of 91%. War in Europe – A World War II-themed mod released in 1999 that includes deathmatch, team deathmatch, and capture the flag. The player earns "promotions" by fragging, which allows purchasing of additional weapons. If the player takes a hit, they will start to bleed, which can be treated with a medkit. PC Gameplay reviewed the game in 2001 and gave a rating of six out of ten, calling it worse than Day of Defeat. Wasteland Half-Life – A post-apocalyptic-themed mod with modes for deathmatch, team deathmatch, and objective capture. PC Zone gave it a score of four out of five and said it's not as popular as it deserves to be. .NetGamer said that despite the familiar gameplay, the mod has a top-notch technical execution. They also praised the maps and the character models. Later, an updated version of the mod was released, titled The Wastes. PC Zone gave it a score 69 out of 100 and called it a worthwhile update.

== External links == "Calcitonin Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2016-03-03. Retrieved 2007-07-23. Calcitonin+receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

Hahn published his results in the Proceedings of the Royal Society on 24 May 1905. It was the first of more than 250 scientific publications in the field of radiochemistry. At the end of his time in London, Ramsay asked Hahn about his plans for the future, and Hahn told him about the job offer from Kalle & Co. Ramsay told him radiochemistry had a bright future, and that someone who had discovered a new radioactive element should go to the University of Berlin. Ramsay wrote to Emil Fischer, the head of the chemistry institute there, who replied that Hahn could work in his laboratory, but could not be a Privatdozent because radiochemistry was not taught there. At this point, Hahn decided that he first needed to know more about the subject, so he wrote to the leading expert on the field, Ernest Rutherford. Rutherford agreed to take Hahn on as an assistant, and Hahn's parents undertook to pay Hahn's expenses. From September 1905 until mid-1906, Hahn worked with Rutherford's group in the basement of the Macdonald Physics Building at McGill University in Montreal. There was some scepticism about the existence of radiothorium, which Bertram Boltwood memorably described as a compound of thorium X and stupidity. Boltwood was soon convinced that it did exist, although he and Hahn differed on what its half-life was. William Henry Bragg and Richard Kleeman had noted that the alpha particles emitted from radioactive substances always had the same energy, providing a second way of identifying them, so Hahn set about measuring the alpha particle emissions of radiothorium.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan-2 a naturally occurring substance?

No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.

How is melanotan-2 distinguished from afamelanotide?

Both are synthetic analogues derived from the same parent hormone. Reference descriptions usually characterise afamelanotide as more selective for the MC1R subtype, whereas melanotan-2 is reported to interact with a wider range of melanocortin receptors.

Why does the compound appear in tanning-related discussion?

Early studies explored melanocortin signalling and pigmentation, which later led to informal use of the label tanning peptide. That label is not a regulatory category and does not imply approved status for any purpose.

What is melanotan-2 chemically?

It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.

Network